Brought to you by:
CLTI: European cohort study provides ‘strong positive evidence’ for surgery over endovascular approach, supporting BEST-CLI results
A recently published study has shown that lower limb bypass surgery offered a significantly higher probability of amputation-free survival and wound healing compared with endovascular treatment in patients with chronic limb-threatening ischemia (CLTI). This and other key findings from the…
The numbers are in: VAM 2023 adds up to another SVS classic
Landmark meeting (June 14-17) with nearly 1,400 vascular professionals moves the needle with program innovations, slew of new science and jam-packed agenda. With more content presented than ever before, a family-friendly Wednesday night gathering, the inaugural Frank J. Veith Distinguished…
Second edition of VSITE review text released
The second edition of a hit trainee-created textbook primarily aimed at those taking the Vascular Surgery In-Training Exam (VSITE) has hit the shelves. The Vascular Surgery Review Book, authored by Thomas Creeden, DO, a resident from the University of Massachusetts in Worcester,…
The top 10 most popular Vascular Specialist stories of June 2023
Last month, Vascular Specialist garnered readers’ attention with an array of commentary on the BEST-CLI and BASIL-2 trials; the medical editor’s interview with vascular surgery’s ‘living legend’ Frank J. Veith, MD; the news of the death of Past SVS President…
VAM 2023 attendees have their say on the impact of BEST-CLI and BASIL-2 trials
As the vascular community continues to unpack the key learnings from two of the biggest trials to date in chronic limb threatening ischemia—BEST-CLI and BASIL-2—attendees of the 2023 Vascular Annual Meeting (VAM) in National Harbor, Maryland (June 14–17) told Vascular…
New analysis probes BEST-CLI trial against real-world setting data
A new analysis of chronic limb-threatening ischemia (CLTI) treatment outcomes was presented at the Society for Cardiovascular Angiography & Interventions (SCAI) 2023 Scientific Sessions (May 18–20) in Phoenix. Since the initial results of the BEST-CLI trial found surgery superior to…
The Big Interview: Pioneering surgeon recounts career as new VAM lectureship is birthed
Vascular Specialist medical editor Malachi Sheahan III, MD, sits down with Frank J. Veith, MD, to discuss his new book, The Medical Jungle, ahead of the maiden named Vascular Annual Meeting (VAM) lecture created in the former SVS President’s honor. The Frank…
VAM attendees chime in on BEST-CLI and BASIL-2
VS@VAM journalist Will Date and videographer Jean-Philippe Bensoussan caught some VAM 2023 foot traffic outside the BEST-CLI and BASIL-2: Debate, Analysis and Implementation session last week to get their take on the two trials and how it has impacted their…
BEST-CLI investigators implore a move beyond endo vs. open ‘battle’ in the name of scientific advance
The principal investigators behind the BEST-CLI trial struck a conciliatory tone during the inaugural Frank J. Veith Distinguished Lecture yesterday morning in which they laid bare the blood, sweat and tears shed on their journey to complete the landmark study.…
Special VAM session underscores ‘complementary’ nature of open and endovascular strategies in CLTI patients
A dedicated session at VAM 2023 saw speakers and delegates gather to debate, analyse and consider the implementation of the BEST-CLI and BASIL-2 randomized-controlled trials (RCTs). There was general agreement that the strategies are complementary, and that “picking the right…